All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Clinical successes related to the vascular endothelial growth factor (VEGF) receptor have come in the form of blockers, such as Genentech's Avastin (bevacizumab). By blocking blood vessel growth, VEGF receptor blockers starve tumor growth